PRODIGE 29-UCGI 26(NEOPAN): A randomised trial of chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (PC)
Ducreux, M.P., Desgrippes, R., Texier, M., Di Fiore, F., Vanelslander, P., Capitain, O., Guimbaud, R., Forestier, J., El Hajbi, F., Follana, P., Parzy, A., Baba Hamed, N., Rinaldi, Y., Brotelle, T., Pignon, J.-P., Jouffroy, C., Dahan, L., Bouche, O.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
2294 Growth modulation index (GMI) to assess salvage chemotherapy benefit after FOLFIRINOX progression in metastatic pancreatic adenocarcinoma
Ducoulombier, A, Quintin, J, Desjardin, M, Hautefeuille, V, Desauw, C, Parzy, A, Bouche, O, Chauffert, B, Clisant, S, El Hajbi, F, Becouarn, Y, Bennouna, J, Hebbar, M, Penel, N, Adenis, A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
3O PRODIGE 68 - UCGI 38 - SOREGATT: A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC)
Ducreux, M.P., Ben Abdelghani, M., Tougeron, D., Bouche, O., Viaud, J., Khemissa Akouz, F., Martin-Babau, J., Bachet, J-B., Coutzac, C., Castanie, H., Taieb, J., Phelip, J.M., Fares, N., Cacheux, W., Etchepare, N., Botsen, D., Mailleux, M., Chevrot, M., Tanguy, M-L., Parzy, A.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
47P Does metastatic site influence the outcome in colorectal cancer patients treated with regorafenib? Insights from the phase II randomized study SOREGATT - PRODIGE 68 - UCGI 38
Smolenschi, C., Tanguy, M-L., Ben Abdelghani, M., Parzy, A., Tougeron, D., Bouche, O., Martin-Babau, J., Bachet, J-B., Taieb, J., Viaud, J., Khemissa Akouz, F., Fares, N., Castanie, H., Etchepare, N., Cacheux, W., Coutzac, C., Botsen, D., Mailleux, M., Ducreux, M.P., Boileve, A.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
1617P PRODIGE 29-UCGI 26 (NEOPAN): Quality of life results of a phase III randomised trial comparing chemotherapy with folfirinox (FFX) or gemcitabine (gem) in locally advanced pancreatic carcinoma (LAPC)
Ducreux, M.P., Desgrippes, R., Rinaldi, Y., Di Fiore, F., Guimbaud, R., Evesque, L., Bachet, J-B., Vanelslander, P., Lecomte, T., Capitain, O., Parzy, A., Bolliet, M., Etienne, P.L., Forestier, J., El Hajbi, F., Bignon Bretagne, A.L., Ly Lebrun, V., De Sousa Carvalho, N., Texier, M., Bouche, O.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
508TiP PRODIGE 68 - UCGI 38 - SOREGATT: A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC)
Ducreux, M.P., Parzy, A., Ben Abdelghani, M., Martin-Babau, J., Tougeron, D., Botsen, D., Taieb, J., Pannier, D., Khemissa, F., Viaud, J., Villing, A.L., Bouche, O., Peytier, A., Alexandre, H., Garic, F., Tanguy, M-L., Bachet, J-B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1296MO PRODIGE 29-UCGI 26(NEOPAN): A phase III randomised trial comparing chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (LAPC)
Ducreux, M.P., Desgrippes, R., Rinaldi, Y., Di Fiore, F., Guimbaud, R., Follana, P., Bachet, J-B., Vanelslander, P., Lecomte, T., Capitain, O., Parzy, A., Bolliet, M., Etienne, P-L., Forestier, J., El Hajbi, F., Bignon Bretagne, A.L., Ly Lebrun, V., De Sousa Carvalho, N., Texier, M., Bouche, O.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
781TiPPRODIGE 29-UCGI 26(NEOPAN): A randomised trial of chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (PC)
Ducreux, M P, Desgrippes, R, Texier, M, Di Fiore, F, Vanelslander, P, Capitain, O, Guimbaud, R, Forestier, J, El Hajbi, F, Follana, P, Parzy, A, Baba Hamed, N, Rinaldi, Y, Brotelle, T, Pignon, J-P, Jouffroy, C, Dahan, L, Bouche, O
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD Groups (Epitopes-HPV02 study)
Kim, S., Francois, E., Bidard, F-C., Samalin, E., El Hajbi, F., Baba-Hamed, N., Dumont, S., Pernot, S., Peiffert, D., Ghiringhelli, F., Bouche, O., Desrame, J., Zoubir, M., Parzy, A., Smith, D., de la Fouchardiere, C., Buecher, B., Vendrely, V., Bonnetain, F., Borg, C.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Prospective analysis of CEA, CA19.9, circulating DNA (cDNA) and circulating tumor cells (CTC) in patients (pts) treated for a metastatic colorectal cancer (mCRC)_Results of COCA-COLON study
Sefrioui, D., Vasseur, N., Toure, E., Blanchard, F., Delacour, J., Thill, C., Beaussire, L., Gillibert, A., Ziegler, F., Gangloff, A., Bouhier-Leporrier, K., Lefebvre, A.-C., Parzy, A., Gallais, M.-P., Clatot, F., Perdrix, A., Sabourin, J.-C., Frebourg, T., Michel, P., Di Fiore, F.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Peut-on boire deux heures avant une endoscopie haute sous anesthésie générale?
Parzy, A, Eloumou, S, Masson, R, Poignavant, C, Dupont, B, Viennot, S, Vastel, E, Joubert, C, Piquet, MA
Published in Endoscopy (01.03.2011)
Published in Endoscopy (01.03.2011)
Get full text
Conference Proceeding